"The necessary steps have been taken by the government to start the...
Category:
Indian News
Latest
NIA’s profit falls almost 17% to Rs 217 crore in Q1FY25
Girija Subramanian,CMD , New India Assurance Going forward, the...
New India’s Lavanya Mundayur selected as CMD of AIC
Lavanya Mundayur, general manager and chief underwriting officer,...
India reports 22,854 new coronavirus cases, 126 deaths in last 24 hrs
Maharashtra, Kerala, Punjab, Karnataka, Gujarat and Tamil Nadu continue to report a high number of fresh COVID-19 cases and together account for 85.91 per cent of the new cases of the coronavirus infection reported in the country in a span of 24 hours, the Union health ministry said on Thursday.Meanwhile, the nationwide COVID-19 vaccination has reported 2,52,89,693 crore coverage, as per the information shared by the union health ministry yesterday.
Passenger vehicle sales in India up 18% in February, shows SIAM data
Commenting on the sales data, SIAM Director General Rajesh Menon said total sales of passenger vehicles from April-February period was still below 2015-16 levels and for two-wheelers it is below 2014-15 levels.
India’s drug regulator panel eases use condition for home-grown vaccine
BENGALURU: An expert panel of India’s drug regulator has recommended relaxing norms for the use of a government-backed coronavirus vaccine after it was found to be highly effective in a late-stage trial, the regulator said on its website on Thursday....
Under Ayushman Bharat, 3 crore women screened for Cancer
“In the past two years, under the Ayushman Bharat Yojana alone, three crore women from poor and rural families got themselves screened for cervical and breast cancer. It means the woman who would have never spoken about the diseases now have support from the government and she utilised the policy and under that she got herself screened, which means she is prepared for a medical challenge and she has prepared herself for solutions,” the union minister said.
India reports 17,921 new coronavirus cases, 133 deaths in last 24 hrs
With 96,548 active coronavirus infections, Maharashtra has the highest number of active cases. Kerala follows with 37,446 active COVID-19 cases. As many as 2,43,67,906 vaccine doses have been administered so far.
Delhi government to open special women mohalla clinics
“In the first phase, 100 ‘Mahila Mohalla Clinics’ are proposed to be established in different parts of Delhi, which will be progressively increased to at least one clinic in each ward. I understand that this is taken in the direction of keeping half of its population respectfully healthy, which will be the most important step so far in the history of 75 years of independent India. For a step such as this, what better time can there be, than the 75th anniversary of our independence,” Deputy Chief Minister Manish Sisodia, said.
Intranasal Covid vaccine candidate in early clinical stage of development in India: Govt
“The interval period between the two doses is presently 21 days. The schedule will be finalized after the phase I clinical trial data. Currently, in phase I clinical trial, single dose and two dose schedules are being tested,” the minister said.
84% of Indians prefer firms that protect personal data
The survey results come at a time when there is no comprehensive data privacy law in place in the country and India is rapidly going digital.
While a majority (78 per cent) of Indian consumers broadly know how many organisations use, store or have access to their personal data (e.g. email address, contact number, bank details etc.), 22 per cent still “don’t have a clue” about it.
IFSCA to soon come up with SPAC regulatory framework: Injeti Srinivas
Srinivas also said that the IFSC can act as the second engine of the Indian economy and be an external engine, which will not only channelize global capital flows into India, but it will also make the external face of India available in this centre.
Pfizer wants to make vaccine in India if faster clearance, export freedom assured -sources
Pfizer and Moderna, whose shots are more expensive than the AstraZeneca one being used in India’s immunisation campaign, are not comfortable with strict price and export restrictions, one of the sources said.